Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH08-02-0122
Issue:2008: 100/4 (Oct) pp. 517-726
Pages:642-647

Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage

Michiel H. Strijbos1, Chandra Rao2, Paul I. M. Schmitz3, Jaco Kraan1, Cor H. Lamers1, Stefan Sleijfer1, Leon W. M. M. Terstappen2, Jan W. Gratama1
1Laboratory of Medical and Tumor Immunology, Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands; 2Immunicon Corporation, Huntingdon Valley, Pennsylvania, USA; 3Department of Trials and Statistics, Erasmus University Medical Center, Rotterdam, The Netherlands

Summary

Increased numbers of circulating endothelial cells (CEC) in peripheral blood have been observed in diseases with vascular involvement, and are considered a promising surrogate marker for vascular damage. It was the objective of this study to evaluate the correlation between putative soluble markers of endothelial injury, activation, and endothelial proliferation, and absolute numbers of CEC. CEC were evaluated in 125 healthy donors and 40 patients with metastatic carcinoma by automated CD146 driven immunomagnetic isolation. Plasma concentrations of E-selectin, endoglin, and thrombomodulin were assessed by ELISA in plasma obtained from 40 healthy donors and 40 patients. CEC numbers in blood were positively correlated with plasma thrombomodulin levels, but not with levels of E-selectin and endoglin. Multivariate analysis demonstrated a significant increase in CEC numbers with age. The levels of plasma biomarkers were not influenced by age. Higher levels of thrombomodulin and E-selectin were observed in males when compared to females. In conclusion, CEC numbers correlate positively with plasma levels of thrombomodulin.

Keywords

endothelium, thrombomodulin, biomarkers, CEC, vascular damage

DOI

http://dx.doi.org/10.1160/TH08-02-0122

You may also be interested in...

1.

Jing-fei Dong1,2*, Miguel A. Cruz1, Khatira Aboulfatova1, Cecilia Martin1, Hiuwan Choi1, Angela L. Bergeron1, Sheryl R. Martini3, Michael H. Kroll1,2, Thomas A. Kent3

Thrombosis and Haemostasis 2008 99 3: 586-593

http://dx.doi.org/10.1160/TH07-11-0694

2.

Bernhard Dorweiler1, Michael Torzewski2, Manfred Dahm1, Charles James Kirkpatrick3, Karl J. Lackner2, Christian-Friedrich Vahl1

Thrombosis and Haemostasis 2008 99 2: 373-381

http://dx.doi.org/10.1160/TH07-06-0387

3.

Davide Noto1*, Santina Cottone2*, Angelo Baldassare Cefalù1, Anna Vadalà2, Carlo Maria Barbagallo1, Manfredi Rizzo1, Vincenzo Pernice3, Mariangela Minà1, Francesca Fayer1, Giovanni Cerasola2, Alberto Notarbartolo1, Maurizio Rocco Averna1

Thrombosis and Haemostasis 2007 98 6: 1362-1367

http://dx.doi.org/10.1160/TH07-06-0414



Articles

You've 516 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...